You are now viewing 1 - 10 of 38 results
September 30, 2009 | Program Result
Brigham and Women's Hospital in Boston conducted a study to see if an improved label design for prescription drugs influenced patients' adherence to essential medications, safety and health outcomes for specific chronic diseases.
December 9, 2005 | Program Result
Richard A. Rawson, Ph.D., evaluated the reasons why naltrexone (a medication-based treatment for alcohol abuse and dependence and opiate addiction) is not widely used by physicians and practitioners.
April 1, 2004 | Program Result
California Health Decisions developed a statewide, pilot education initiative called Healthcare 101: Choosing and Using Prescription Medicines.
August 16, 2004 | Program Result
From 2000 to 2001, researchers at Boston University School of Public Health examined how the growth of direct-to-consumer advertising of prescription drugs affects the patient-provider relationship.
March 1, 2003 | Program Result
The Leapfrog Group developed standards for evaluating hospitals' use of computerized physician order entry systems, and devised and tested techniques to raise awareness about the importance of considering the presence of systems.
August 1, 2003 | Program Result
During 1999 and 2000, Brenda Motheral, PhD, and researchers at the University of Arizona Health Sciences Center examined the impact that a cap (or limit) on prescription drug benefits has on the drug-taking behavior of beneficiaries ages 65 or older who are enrolled in Medicare HMO plans.
December 1, 2003 | Program Result
During 2002 and 2003, the Neighborhood Health Clinic in Naples, Fla. created a new state-of-the-art Medication Room to improve the delivery of medications to its 12,000 clients.
January 1, 2001 | Program Result
During the 1980s, expenditures on pharmaceuticals nationwide increased by 152 percent. HMOs implemented a number of cost-control mechanisms to slow the rate of growth of pharmaceutical expenditures, and were successful in doing so compared to fee-for-service health plans.
March 6, 2008 | Program Result
Researchers at Brandeis University used data from two state-run prescription drug programs for low-income seniors to examine how differences in prescription drug coverage affect enrollment, drug use and spending in state programs.
July 31, 2008 | Program Result
Pharmacogenomics is the study of how inherited variations in genes dictate a person's reaction to a drug. Louis F. Rossiter, PhD, and other researchers examined how pharmacogenomics fits within the current health care market.